Articles
27. 10. 2015 Cancer in the older population of the Czech Republic
Population ageing has become a challenge to cancer care in developed countries. Particularities of the older population must be taken into account when considering cancer treatment. However, there is a lack of consensus on guidelines for this population due to the underrepresentation of older patients in clinical trials.
15. 1. 2014 Personalised invitations of Czech citizens to cancer screening programmes
In January 2014, a project of personalised invitations for cancer screening programmes was launched in the Czech Republic. In particular, citizens are invited to participate in colorectal cancer screening (men and women), as well as breast cancer screening and cervical cancer screening (women). Personalised invitations are aimed at citizens who have not participated in cancer screening programmes in the long term, and therefore are at a higher risk of developing cancer. The project is expected to increase participation rates in Czech cancer screening programmes.
» Archive
Detail KOC
Comprehensive Cancer Centre of University Hospital in Motol, Prague
- Identification data
- Basic characteristics
- Contractual relationships with health insurance companies
- Hospital and management information systems
- Healthcare quality assessment and documentation
- clinical assessment
Identification data
| Official title of CCC: | Comprehensive Cancer Centre of University Hospital in Motol, Prague |
| Head of the centre: | Prof. Tomáš Büchler, M.D., Ph.D. |
| Title of healthcare facility: | University Hospital in Motol |
| Director of the healthcare facility: | Miloslav Ludvík, J.D., M.Sc., M.B.A. |
| City: | Praha |
Cooperating healthcare facilities, clinics and departments including contact data:
| Name of clinic/department: | Department of Radiotherapy and Oncology, University Hospital in Motol |
| Head: | Prof. Tomáš Büchler, M.D., Ph.D. |
| Address: | V úvalu 84/1, 150 06 Praha 5 |
| Phone: | +420 224 434 700 |
| e-mail: | tomas.buchler@fnmotol.cz |
| Name of clinic/department: | Department of Paediatric Haematology and Oncology, University Hospital in Motol |
| Head: | Prof. Jan Starý, M.D., Ph.D. |
| Address: | V úvalu 84/1, 150 06 Praha 5 |
| Phone: | +420 224 436 401 |
| e-mail: | kdho@lfmotol.cuni.cz |
Data authorization: 9. 9. 2014, prim. MUDr. Zdeněk Linke
Basic characteristics
Beds and outpatient departments:
| Total number of beds available for cancer patients: | 57 |
| Total number of oncology outpatient departments: | 9 |
Medical equipment:
 Spiral computed tomography:
|
 MRI:
|
|
 PET:
|
 Classical mammography machine
|
|
 Digital mammography machine:
|
 Endoscopic ultrasound (EUS):
|
|
Other equipment:
Data authorization: 9. 9. 2014, prim. MUDr. Zdeněk Linke
Contractual relationships with health insurance companies
Contractual relationships with healthcare payers:
| 111 - Všeobecná zdravotní pojišťovna ČR |  |
| 201 - Vojenská zdravotní pojišťovna ČR | |
| 205 - Česká průmyslová zdravotní pojišťovna | |
| 207 - Oborová zdravotní pojišťovna zaměstnanců bank, pojišťoven a stavebnictví | |
| 209 - Zaměstnanecká pojišťovna Škoda | |
| 211 - Zdravotní pojišťovna ministerstva vnitra ČR | |
| 213 - Revírní bratrská pokladna, zdravotní pojišťovna | |
Data authorization: 9. 9. 2014, prim. MUDr. Zdeněk Linke
Hospital and management information systems (HIS and MIS)
For the documentation of diagnostic and therapeutic processes in cancer patients, the centre employs a fully electronic Hospital Information System (HIS):
| HIS identification: | Unis-Steiner, C1994, revize 14/2/2006 |
| HIS provider: | Steiner |
The HIS employed in the centre enables a parametric collection of cancer data, at least in the extent of the report sent to the National Cancer Registry:
| Parametrization only in the extent of the report sent to the National Cancer Registry: |  |
| Parametrization includes records beyond the report sent to the National Cancer Registry: | |
Which of the following data are parametrically recorded within the HIS and which of them are easily available for the centre's management:
| Data | Údaj parametricky zaznamenáván v NIS |
Údaj pohodlně dostupný pro vedení centra |
| Total number of diagnosed and/or treated patients | |
|
| Number of diagnosed and/or treated patients sorted by diagnoses | |
|
| Staging at the time of diagnosis (TNM, clinical stage etc.) | |
|
| Results of histopathological examination (pTNM, grade etc.) | |
|
| Results of laboratory examination | |
|
| Results of examination by imaging methods | |
|
| Records on anticancer pharmacotherapy (regimens, products, doses etc.) | |
|
| Records on radiation therapy | |
|
| Records on adverse drug reactions | |
|
The centre employs a Management Information System (MIS):
The centre employs filmless technologies and telemedicine tools:
| HIS identification : | |
| HIS provider: |
The centre employs an information system controlling the preparation of anticancer pharmacotherapy:
| The system enables a central drug preparation: | |
| The system allows an on-line ordering of pharmacotherapy: | |
Data authorization: 9. 9. 2014, prim. MUDr. Zdeněk Linke
Healthcare quality assessment and documentation
The documentation of diagnostic and therapeutic processes in cancer patients is maintained:
in an existing Hospital Information System (HIS) with text records prevailing over parametric records
Documentation status of diagnostic and therapeutic processes in cancer patients:
A complete documentation is easily available on cancer patients - including the findings of examination by imaging methods either in classical or digital form, and archived histological material:
Informed consents of cancer patients are archived and available:
Documentation on all stages of anticancer therapy - i.e. operation protocols, records on radiation therapy and chemotherapy - is maintained in line with specific standards and easily available:
The centre is interested in the evaluation of its cancer diagnostics and treatment, using self-evaluation and local programmes aimed at healthcare quality check, if appropriate methodology is available:
The centre is interested in the electronic version of cancer patients' case report forms:
For the following reason: The centre is rebuilding its current system of data collection within the HIS
The centre follows recommended guidelines (standards) of cancer diagnostics and therapy:
The centre uses standards created by another authority:
The centre has its own system to monitor diagnostic and therapeutic standards:
Data authorization: 9. 9. 2014, prim. MUDr. Zdeněk Linke
Clinical trials and implementation of new procedures
The centre has a local ethical commision at its disposal:
The centre is willing and has the capacity to take part in new multicentre clinical trials and registries:
Number of clinical trials (being conducted in compliance with the Good Clinical Practice) in which the centre currently participates:
| Phase I: |
Total number: 3 Number of international projects: 2 |
| Phase II: |
Total number: 7 Number of international projects: 2 |
| Phase III: |
Total number: 18 Number of international projects: 4 |
| Phase IV: |
Total number: 4 Number of international projects: 0 |
The centre is involved in Czech or international clinical registries:
(out of National Cancer Registry, i.e. projects concerned with genetics etc.)
| Project title | Identification of project organizers | Diagnosis of registered patients | The centre has been actively participating in the registry since |
| výzkumný záměr-genetika | FN v Motole+ MZd | 2000 | |
| EORTC -SARCOMA G. | EORTC | sarkomy | 2001 |
| KLS | VFN | NHL | 1999 |
| ESIOP-neuroblastom | ESIOP | neurobl. | 2001 |
| CMG | Bohunice | plasmocyt. | 1999 |
| klinické registry (GIST, NET, Breast, Corect, Tulung, Renis, EGFR, ...) | IBA MU | 2007 |
The centre actively participates in prevention programmes:
Primary prevention: -
Secondary prevention:
The centre organizes its own projects of a nationwide significance in the following areas:
| Diagnostics: | pathology: radiodiagnostics: nuclear medicine: |
|
| Therapy: | chemotherapy: radiation therapy: biological therapy: |
|
Genomics and proteomics:
Pharmacogenetics:
Data authorization: 9. 9. 2014, prim. MUDr. Zdeněk Linke
